Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial

Abstract: Hepatic toxicity is the most serious adverse effect of anti-tuberculosis drugs. This study was performed to evaluate the efficacy of silymarin as a hepatoprotective herbal agent. In a randomized double blind clinical trial, 70 new cases of pulmonary tuberculosis were divided into two grou...

Full description

Bibliographic Details
Main Authors: Marjani, Majid, Baghaei, Parvaneh, Kazempour Dizaji, Mehdi, Gorji Bayani, Pegah, Fahimi, Fanak, Tabarsi, Payam, Velayati, Ali Akbar
Format: Online
Language:English
Published: Shaheed Beheshti University of Medical Sciences 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986122/